HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 283, Issue 14, 8995-9001, April 4, 2008

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 283/14/8995    most recent M707203200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Antonson, P. Articles by Gustafsson, J.-A. Search for Related Content PubMed PubMed Citation Articles by Antonson, P. Articles by Gustafsson, J.-A. Social Bookmarking                      What's this?

RAP250 Is a Coactivator in the Transforming Growth Factor β Signaling Pathway That Interacts with Smad2 and Smad3^*

From the Department of Biosciences and Nutrition, Karolinska Institutet, Novum, S-14157 Huddinge, Sweden

RAP250 is a coactivator for nuclear receptors as well as other transcription factors. Recent studies have established RAP250 as an essential coactivator for many important biological processes, but its exact mechanism of action is not fully understood. To identify novel proteins that can associate with RAP250, we used a yeast two-hybrid system to screen cDNA libraries and identified the intracellular mediators of transforming growth factor-β (TGF-β) response Smad2 and Smad3 as direct interacting proteins. We show that the interaction between RAP250 and Smad2/3 is dependent upon the second LXXLL interaction motif in RAP250 and the MH2 domain in Smad2 and Smad3. Mouse embryonic fibroblasts lacking RAP250 have reduced expression of the TGF-β target gene PAI-1 after stimulation by TGF-β when compared with wild type cells. Furthermore, we demonstrate a cross-talk between TGF-β and liver X receptors (LXR) signaling pathways and show that stimulation of cells with TGF-β and LXR agonists have a synergistic effect on the expression of the LXR target gene ABCG1. Our data identify RAP250 as a new coactivator in the TGF-β signaling pathway that binds Smad2 and Smad3. Our data also suggest that the interaction between RAP250, Smad2, and Smad3 constitutes an important bridging mechanism linking LXR and TGF-β signaling pathways.

Received for publication, August 28, 2007 , and in revised form, February 4, 2008.

^* This study was supported by grants from the Swedish Science Council. J.-Å. G. is a shareholder, research grant recipient, and consultant of Karo Bio AB. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at http://www.jbc.org) contains five supplemental figures.

¹ To whom correspondence should be addressed. Tel.: 46-8-6089147; Fax: 46-8-7745538; E-mail: per.antonson{at}biosci.ki.se.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				X. Fan, H.-J. Kim, D. Bouton, M. Warner, and J.-A. Gustafsson Expression of liver X receptor {beta} is essential for formation of superficial cortical layers and migration of later-born neurons PNAS, September 9, 2008; 105(36): 13445 - 13450. [Abstract] [Full Text] [PDF]